Outpatient medical abortion is safe and effective through 70 days gestation

被引:32
作者
Abbas, Dina [1 ]
Chong, Erica [1 ]
Raymond, Elizabeth G. [1 ]
机构
[1] Gynu Hlth Projects, New York, NY 10010 USA
关键词
UNITED-STATES; MIFEPRISTONE; MISOPROSTOL; TERMINATION; PREGNANCY; REGIMEN;
D O I
10.1016/j.contraception.2015.06.018
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Data show that an outpatient regimen of 200-mg mifepristone followed by a single dose of misoprostol is safe and effective for medical abortion for up to 70 days from last menstrual period (LMP). Yet, many clinics only provide services up to 63 days LMP, and some practice guidelines do not recommend the higher gestational age limit. We review the studies published to date that include women 64 to 70 days LMP and conclude that outpatient medical abortion is safe and effective in this interval and that there are no clinically meaningful differences between outcomes at 57 to 63 days LMP and 64 to 70 days LMP. Updating clinical protocols and revising the Food and Drug administration label for Mifeprex (R) to change the indication for termination of pregnancies through 70 days LMP will give women more choices and expand access to safe abortion services. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:197 / 199
页数:3
相关论文
共 50 条
[41]   Single dose letrozole and misoprostol for termination of pregnancy through 63 days? gestation: A pilot study * , ** [J].
Shochet, Tara ;
Turok, David ;
Sexsmith, Corinne D. ;
Gawron, Lori M. ;
Kaiser, Jennifer E. ;
Winikoff, Beverly .
CONTRACEPTION, 2023, 120
[42]   Roles of pharmacists in expanding access to safe and effective medical abortion in developing countries: A review of the literature [J].
Sneeringer, Robyn K. ;
Billings, Deborah L. ;
Ganatra, Bela ;
Baird, Traci L. .
JOURNAL OF PUBLIC HEALTH POLICY, 2012, 33 (02) :218-229
[43]   Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation [J].
Whitehouse, Katherine C. ;
Shochet, Tara ;
Lohr, Patricia A. .
CONTRACEPTION, 2022, 110 :21-26
[44]   Expanding a woman's options to include home use of misoprostol for medical abortion up until 76 days: an observational study of efficacy and safety [J].
Larsson, Amanda ;
Ronnberg, Ann-Kristin M. .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2019, 98 (06) :747-752
[45]   Increasing access to safe abortion services in rural India: experiences with medical abortion in a primary health center [J].
Mundle, Shuchita ;
Ejul, Batya ;
Anand, Abhijeet ;
Kalyanwala, Shveta ;
Ughade, Suresh .
CONTRACEPTION, 2007, 76 (01) :66-70
[46]   Integrating medical abortion into safe abortion services: experience from three pilot sites in South Africa [J].
Kawonga, Mary ;
Blanchard, Kelly ;
Cooper, Diane ;
Cullingworth, Lee ;
Dickson, Kim ;
Harrison, Teresa ;
von Mollendorf, Claire ;
Winikoff, Beverly .
JOURNAL OF FAMILY PLANNING AND REPRODUCTIVE HEALTH CARE, 2008, 34 (03) :159-164
[47]   Early medical abortion before missed menses: a prospective observational study of outcomes of abortion at less than 30 days from last menstrual period [J].
Wheate, Elizabeth April ;
Reynolds-Wright, John Joseph ;
Cameron, Sharon T. .
BMJ SEXUAL & REPRODUCTIVE HEALTH, 2025,
[48]   Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases [J].
Hamoda, H ;
Ashok, PW ;
Flett, GMM ;
Templeton, A .
CONTRACEPTION, 2005, 71 (05) :327-332
[49]   A randomized clinical trial comparing the short-term side effects of sublingual and buccal routes of misoprostol administration for medical abortions up to 63 days' gestation [J].
Chai, Joyce ;
Wong, Ching Yin Grace ;
Ho, Pak Chung .
CONTRACEPTION, 2013, 87 (04) :480-485
[50]   A pilot study of mifepristone and misoprostol administered at the same time for abortion in women with gestation from 50 to 63 days [J].
Schreiber, CA ;
Creinin, MD ;
Harwood, B ;
Murthy, AS .
CONTRACEPTION, 2005, 71 (06) :447-450